Blend Therapeutics Obtains $999,999 New Funding Round

  • Feed Type
  • Date
  • Company Name
    Blend Therapeutics
  • Mailing Address
    134 Coolidge Avenue Watertown, MA 02472
  • Company Description
    Blend is pioneering controlled combination medicines that overcome the limitations of conventional combination therapy through their unprecedented ability to hit distinct disease pathways with multiple drugs in concert—at the desired sites, at the most effective concentrations, and for the right durations—to drive optimal effects from each drug on the disease process.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy